Janus Henderson Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Hold |
31,038
| – | – | ﹤0.01% | 2243 |
|
|
2025
Q1 | $254K | Buy |
31,038
+13,000
| +72% | +$106K | ﹤0.01% | 2276 |
|
|
2024
Q4 | $268K | Hold |
18,038
| – | – | ﹤0.01% | 2301 |
|
|
2024
Q3 | $276K | Hold |
18,038
| – | – | ﹤0.01% | 2303 |
|
|
2024
Q2 | $274K | Sell |
18,038
-218
| -1% | -$3.32K | ﹤0.01% | 2246 |
|
|
2024
Q1 | $345K | Sell |
18,256
-30
| -0.2% | -$567 | ﹤0.01% | 2174 |
|
|
2023
Q4 | $349K | Sell |
18,286
-35
| -0.2% | -$669 | ﹤0.01% | 2160 |
|
|
2023
Q3 | $329K | Buy |
18,321
+4
| +0% | +$72 | ﹤0.01% | 2144 |
|
|
2023
Q2 | $372K | Sell |
18,317
-24
| -0.1% | -$487 | ﹤0.01% | 2138 |
|
|
2023
Q1 | $334K | Buy |
+18,341
| New | +$334K | ﹤0.01% | 2229 |
|
|
2022
Q4 | – | Sell |
-8,002
| Closed | -$209K | – | 2492 |
|
|
2022
Q3 | $209K | Sell |
8,002
-94
| -1% | -$2.46K | ﹤0.01% | 2388 |
|
|
2022
Q2 | $205K | Buy |
8,096
+122
| +2% | +$3.09K | ﹤0.01% | 2291 |
|
|
2022
Q1 | $252K | Sell |
7,974
-7
| -0.1% | -$221 | ﹤0.01% | 2322 |
|
|
2021
Q4 | $323K | Buy |
+7,981
| New | +$323K | ﹤0.01% | 2167 |
|
|
2020
Q1 | – | Sell |
-296,000
| Closed | -$2.99M | – | 1399 |
|
|
2019
Q4 | $2.99M | Sell |
296,000
-204,654
| -41% | -$2.07M | ﹤0.01% | 1123 |
|
|
2019
Q3 | $4.56M | Sell |
500,654
-6,875
| -1% | -$62.6K | ﹤0.01% | 1068 |
|
|
2019
Q2 | $4.04M | Buy |
507,529
+681
| +0.1% | +$5.41K | ﹤0.01% | 1076 |
|
|
2019
Q1 | $6.33M | Sell |
506,848
-391
| -0.1% | -$4.88K | ﹤0.01% | 970 |
|
|
2018
Q4 | $5.46M | Buy |
507,239
+36,937
| +8% | +$398K | ﹤0.01% | 959 |
|
|
2018
Q3 | $6.56M | Buy |
470,302
+787
| +0.2% | +$11K | ﹤0.01% | 988 |
|
|
2018
Q2 | $5.75M | Buy |
469,515
+928
| +0.2% | +$11.4K | ﹤0.01% | 1005 |
|
|
2018
Q1 | $7.24M | Buy |
+468,587
| New | +$7.24M | ﹤0.01% | 952 |
|